Publication | Closed Access
Screening for TORCH infections in pregnant women: a report from Delhi.
39
Citations
0
References
1999
Year
GynecologyPathologyHigh-risk PregnancyMaternal ImmunizationHealthcare-associated InfectionClinical EpidemiologySerologic TestingObstetricsPublic HealthPrimary Torch InfectionsMaternal HealthVirologyMaternal-fetal MedicineToxoplasma GondiiPathogenesisTorch InfectionsHerpesvirusesClinical InfectionPregnant WomenMedicine
Primary TORCH infections (toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus type 1 and 2) in the mother can lead to severe fetal anomalies or even fetal loss. A prospective study was designed to detect the seroprevalence of IgM antibodies to Toxoplasma gondii, rubella virus and cytomegalovirus and IgG antibodies to herpes simplex virus type 1 and 2. One hundred and twenty pregnant women presenting to the antenatal clinic of a tertiary health center were included in this study. Out of these 120 women 112 (93.4%) had evidence of one or more infections. Prevalence of IgG antibodies to HSV was 70%. Seropositivities for toxoplasmosis, rubella and CMV respectively were 11.6, 8.3 and 20.8%. Our data demonstrating high frequency of primary infections during pregnancy support the conclusion that routine prenatal TORCH screening is justified.